HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc. (“IMPAX” or the “Company”) reports that on May 23, 2008 the U.S. Securities and Exchange Commission (“SEC”) issued an order revoking the registration of the Company’s common stock under section 12(g) of the Securities and Exchange Act of 1934. The effect of this action is that broker-dealers are now prohibited from effecting transactions in the stock until the Company has filed a registration statement on Form 10 pursuant to section 12(g) and such registration statement has become effective. The Company expects to have the required audits completed and to file its Form 10 registration statement on or about June 30, 2008 or shortly thereafter. Section 12(g) provides that registration statements thereunder shall become effective within 60 days after filing.
